EMA CHMP gives positive opinion on linvoseltamab for relapsed/refractory myeloma patientsAccess, Myeloma, NewsMarch 3, 2025
Europe’s Beating Cancer Plan and its progress to date on rare cancersAccess, latest, NewsFebruary 28, 2025
MPE member spotlight: Fundacja Carita´s European Forum of Haemato-Oncological PatientsMPE, NewsFebruary 6, 2025
Register for MPE´s European Young Myeloma Patients Group webinar on myeloma and physical fitnessMPE, Myeloma, NewsFebruary 5, 2025
The European Commission approves isatuximab + VRd combination therapy for newly diagnosed, transplant ineligible myeloma patientsAccess, Myeloma, NewsJanuary 24, 2025
MPE webinar on ASH 2024 myeloma and AL amyloidosis highlightsAL amyloidosis, latest, MPE, Myeloma, NewsNovember 29, 2024
MPE provided feedback on the HTA Implementing Regulation on joint scientific consultations on medical devices and in vitro diagnostic medical devices at Union levellatest, MPE, NewsNovember 27, 2024
EMA CHMP gives positive opinion on isatuximab combination for newly diagnosed myeloma patientsAccess, latest, Myeloma, NewsNovember 20, 2024
MPE comments on the European Medicines Agency’s policy on the handling of competing interests of scientific committees’ members and expertsMPE, NewsNovember 14, 2024
